Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723694 · ClinicalTrials.gov registry record · NA
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 259
- Enrollment target
NCT03723694 is a NA study that has completed, run by Columbia University. The registered enrollment target is 259 participants.
The verdict
NCT03723694, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of a cocoa-derived dietary flavanol on brain structures and cognitive outcomes in a 12-week randomized controlled trial of 146 healthy participants, age 50-69, who will receive this cocoa derivative or a placebo. Th investigators will also examine the role of inflammation in this relationship.
Interventions
- DIETARY_SUPPLEMENT 650 mg of Cocoapro flavanols
- DIETARY_SUPPLEMENT 0 mg of Cocoapro flavanols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03723694
The ClinicalTrials.gov registry entry for NCT03723694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 650 mg of Cocoapro flavanols is the first listed.
NCT03723694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03723694 about?
NCT03723694 is a clinical study titled "Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders". The purpose of this study is to test the effect of a cocoa-derived dietary flavanol on brain structures and cognitive outcomes in a 12-week randomized controlled trial of 146 healthy participants, age 50-69, who will receive this cocoa derivative or a placebo. Th investigators will also examine the ...
What is the current status of trial NCT03723694?
This trial is currently completed. It is a NA study. The enrollment target is 259 participants. The study started on 2019-01-01. Estimated completion is 2023-06-26.
What interventions are being tested in trial NCT03723694?
The interventions under investigation include: 650 mg of Cocoapro flavanols (DIETARY_SUPPLEMENT), 0 mg of Cocoapro flavanols (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03723694?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.